You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Relapsed hematologic malignancy

Showing 26 - 50 of 8,407
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hematologic Malignancy, AML, ALL Trial in Australia, United States (Tagraxofusp, Fludarabine, Cytarabine)

Not yet recruiting
  • Hematologic Malignancy
  • +10 more
  • Los Angeles, California
  • +28 more
Jul 26, 2022

Hematologic Malignancy Trial (Cold-stored platelet concentrate)

Not yet recruiting
  • Hematologic Malignancy
  • Cold-stored platelet concentrate
  • (no location specified)
Apr 14, 2023

Thoracic Scanographic Characteristics of Hematologic Malignancy

Recruiting
  • Mediastinal Diseases
  • analysis of thoracic scans
  • Toulouse, France
    Muriel Picard
Jan 12, 2023

Hematologic Malignancy Trial in Zhejiang (IBI322)

Recruiting
  • Hematologic Malignancy
  • IBI322
  • Zhejiang, China
    The Second Affiliated Hospital Zhejiang University School of Med
Sep 12, 2022

Acute Lymphoblastic Leukemia, Non-hodgkin Lymphoma Trial in Hangzhou (CTA101)

Recruiting
  • Acute Lymphoblastic Leukemia
  • Non-hodgkin Lymphoma
  • Hangzhou, Zhejiang, China
    The First Hospital of Zhejiang Medical Colleage Zhejiang Univers
Dec 24, 2020

Venous Thromboembolism in Hematologic Malignancy and

Active, not recruiting
  • Thrombosis, Venous
  • +4 more
    • Toronto, Ontario, Canada
      Federico Carini
    Nov 21, 2022

    Oral Complications in Hematological Malignancies

    Not yet recruiting
    • Hematologic Malignancy
      • Assiut, Egypt
        Assiut university
      Mar 6, 2023

      Hematologic Malignancy Trial in Milwaukee (Tacrolimus, Methotrexate, Tocilizumab)

      Active, not recruiting
      • Hematologic Malignancy
      • Milwaukee, Wisconsin
        Froedtert Hospital
      Jan 31, 2023

      Hematologic Malignancy Trial in Nanchang, Jinan (TQB3702 tablets)

      Not yet recruiting
      • Hematologic Malignancy
      • TQB3702 tablets
      • Nanchang, Jiangxi, China
      • +1 more
      Nov 2, 2022

      Graft Vs Host Disease, Graft-versus-host-disease, Acute Myeloid Leukemia Trial (CliniMACS® device)

      Not yet recruiting
      • Graft Vs Host Disease
      • +5 more
      • CliniMACS® device
      • (no location specified)
      Jul 20, 2023

      Hematologic Malignancy Trial in Bologna

      Recruiting
      • Hematologic Malignancy
        • Bologna, Italy
          Programma Dipartimentale Terapie Cellulari Avanzate
        Apr 17, 2023

        Allogeneic Hematopoietic Stem Cell Transplant Recipient, Myeloproliferative Tumor, Recurrent Acute Lymphoblastic Leukemia Trial

        Completed
        • Allogeneic Hematopoietic Stem Cell Transplant Recipient
        • +10 more
        • Ipilimumab
        • +2 more
        • Duarte, California
        • +12 more
        Jun 23, 2021

        Non-hodgkin Lymphoma, Acute Lymphoblastic Leukaemia, Chronic Lymphocytic Leukemia Trial in Tianjin (CC312)

        Recruiting
        • Non-hodgkin Lymphoma
        • +2 more
        • CC312
        • Tianjin, Tianjin, China
          InstituteHBDH
        Sep 12, 2023

        Hematopoietic Stem Cell Transplantation, Hematologic Malignancy Trial (CliniMACS®)

        Not yet recruiting
        • Hematopoietic Stem Cell Transplantation
        • Hematologic Malignancy
        • CliniMACS®
        • (no location specified)
        Oct 17, 2023

        SARS-CoV-2 Infection in Hematologic Tumors

        Active, not recruiting
        • SARS-CoV-2 Infection
        • Hematologic Malignancy
        • None intervention
        • Beijing, Beijing, China
          Peking University First Hospital
        Jan 13, 2023

        Hematologic Diseases, Tumors Trial in Hangzhou (CD7 CAR-T cells injection, Allogeneic hematopoietic stem cell transplantation)

        Recruiting
        • Hematologic Diseases
        • Neoplasms
        • CD7 CAR-T cells injection
        • Allogeneic hematopoietic stem cell transplantation
        • Hangzhou, Zhejiang, China
          The first affiliated hospital of medical college of zhejiang uni
        Apr 11, 2023

        Hematological Malignancy, Neutropenia Trial in Morgantown (Eravacycline)

        Not yet recruiting
        • Hematological Malignancy
        • Neutropenia
        • Morgantown, West Virginia
          Aaron Cumpston
        Sep 12, 2022

        Aggressive B-Cell Non-Hodgkin's Lymphoma, Aggressive B-Cell NHL, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Trial

        Not yet recruiting
        • Aggressive B-Cell Non-Hodgkin's Lymphoma
        • +4 more
        • (no location specified)
        Dec 16, 2022

        Hematologic Malignancy, Hematologic Tumors, Hematologic Diseases Trial in Nanjing, Suzhou, Tianjin (Flow Cytometry)

        Not yet recruiting
        • Hematologic Malignancy
        • +2 more
        • Flow Cytometry
        • Nanjing, Jiangsu, China
        • +2 more
        Apr 17, 2023

        Cognitive Impairment, Hematologic Malignancy Trial in Birmingham (Modified ketogenic diet using an exogenous ketogenic formula,

        Recruiting
        • Cognitive Impairment
        • Hematologic Malignancy
        • Modified ketogenic diet using an exogenous ketogenic formula
        • Online cognitive training
        • Birmingham, Alabama
          University of Alabama at Birmingham
        Jan 31, 2023

        19 and 22+ B Cell Hematologic Tumors Trial in Wuhan (Autologous CD19/CD22 Chimeric Antigen Receptor T-cells)

        Recruiting
        • 19 and 22+ B Cell Hematologic Tumors
        • 19 and 20+ B Cell Hematologic Tumors
        • Autologous CD19/CD22/CD20 Chimeric Antigen Receptor T-cells
        • Wuhan, Hubei, China
          Tongji Hospital
        Jan 11, 2023

        Tumor, Plasma Cell, Lymphoma Trial in Toulouse (Comprehensive Geriatric Assessment)

        Recruiting
        • Neoplasm, Plasma Cell
        • Lymphoma
        • Comprehensive Geriatric Assessment
        • Toulouse, France
          University Hospital Toulouse
        Oct 12, 2022

        Prospective Validation of the OHI Index

        Recruiting
        • HLH
        • +4 more
          • Kfar Saba, Israel
          • +1 more
          May 21, 2023

          Hematologic Malignancy Trial in Boston (Home Transfusion Program Components)

          Not yet recruiting
          • Hematologic Malignancy
          • Home Transfusion Program Components
          • Boston, Massachusetts
            Dana-Farber Cancer Institute
          Aug 18, 2022

          Relapsed or Refractory B-cell Hematologic Malignancies Trial in Beijing, Nanjing (HEC89736)

          Active, not recruiting
          • Relapsed or Refractory B-cell Hematologic Malignancies
          • Beijing, Beijing, China
          • +1 more
          May 5, 2022